Premium
Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency ( PKD )?: Toward an expanded definition of severe PKD
Author(s) -
Schwartz Jonathan D.,
Barcellini Wilma,
Grace Rachel F.,
Bianchi Paola,
Zanella Alberto,
López Lorenzo José Luis,
Sevilla Julián,
Shah Ami J.,
Glader Bertil,
Nicoletti Eileen,
Navarro Ordoñez Susana,
Segovia José Carlos
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26458
Subject(s) - pyruvate kinase deficiency , medicine , pyruvate kinase , hemolysis , immunology , red cell , cancer research , glycolysis , metabolism